SMED Clinical Research

SMED Clinical Research is a newly established, private clinical research services company leveraging over 20 years of founder expertise to offer integrated medical advisory and CRO services. Its core differentiator is combining traditional clinical development rigor with advanced data science and a practical, site-centric perspective to optimize trial design and execution. The company aims to be a global partner, utilizing technology and a collaborative model to increase the efficiency and probability of success for client-sponsored trials in oncology, rare diseases, and other complex therapeutic areas.

Integrated data science and AI/ML platform for clinical trial optimization, focusing on machine learning-driven biomarker and genomic signature discovery for drug modeling and trial design.

SMED competes in a fragmented but crowded market dominated by large, full-service global CROs (e.g., IQVIA, ICON) and many niche consultancies. Its differentiation hinges on its founder's deep expertise, integrated site perspective, and application of AI/ML, but it must prove these offer tangible advantages over competitors' scale and resources.